Filing Details
- Accession Number:
- 0000899243-20-030857
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-12 17:51:37
- Reporting Period:
- 2020-11-09
- Accepted Time:
- 2020-11-12 17:51:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1805387 | Cerevel Therapeutics Holdings Inc. | CERE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1432313 | R Christopher Gordon | C/O Bain Capital Investors, Llc 200 Clarendon Street Boston MA 02116 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-09 | 332,293 | $10.30 | 60,632,356 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
Footnotes
- On November 9, 2020, BC Perception Holdings, LP ("BC Perception") purchased 332,293 shares of the Issuer's Common Stock at a price of $10.30 per share.
- Christopher Gordon is a Managing Director of Bain Capital Investors, LLC ("BCI"), the ultimate general partner of BC Perception. Voting and investment decisions with respect to securities held by BC Perception are made by the managing directors of BCI. As a result, Mr. Gordon may be deemed to share voting and dispositive power with respect to the securities held by BC Perception. Mr. Gordon disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.